COR
What one share of Cencora holds
Wholesale – Drugs, Proprietaries and Druggists' Sundries
Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.
Cencora’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1,707 |
|---|---|
| Profit | $13.46 |
| Capex (buildings and equipment) | $3.90 |
| Free cash flow | $20.82 |
| Dividends | $2.35 |
| Cash and investments | $14.75 |
| Debt | $59.97 |
| Book value | $15.99 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $649.90 | $6.32 | $2.06 | $12.01 | $1.36 | $9.68 |
| 2017 | $691.08 | $1.64 | $2.10 | $4.68 | $1.46 | $9.47 |
| 2018 | $762.20 | $7.53 | $1.53 | $4.88 | $1.52 | $13.76 |
| 2019 | $847.76 | $4.04 | $1.46 | $9.60 | $1.60 | $13.92 |
| 2020 | $927.29 | −$16.65 | $1.81 | $8.97 | $1.66 | −$4.99 |
| 2021 | $1,026 | $7.39 | $2.10 | $10.69 | $1.76 | $1.07 |
| 2022 | $1,130 | $8.04 | $2.35 | $10.45 | $1.84 | −$1.03 |
| 2023 | $1,281 | $8.53 | $2.24 | $16.88 | $1.94 | $2.60 |
| 2024 | $1,468 | $7.53 | $2.43 | $14.97 | $2.04 | $3.31 |
| 2025 | $1,646 | $7.96 | $3.42 | $16.43 | $2.20 | $7.78 |